{"id":"W2153771870","doi":"10.1016/j.addr.2013.11.009","title":"Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology","year":2013,"lang":"en","type":"review","venue":"Advanced Drug Delivery Reviews","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":2762,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institute of Biomedical Imaging and Bioengineering; National Cancer Institute; National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research","keywords":"Commercialization; Nanomedicine; Medicine; Nanotechnology; Tolerability; Cancer; Drug development; Personalized medicine; Drug; Pharmacology; Nanoparticle; Bioinformatics; Internal medicine; Business; Adverse effect; Materials science; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}